The official journal of the International Menopause Society (IMS), Climacteric, the Journal of Adult Women’s Health & Medicine, publishes international, original, peer-reviewed research and reviews on all aspects of aging in men and women, especially during the menopause and climacteric. The content of the journal covers the whole range of subject areas relevant to climacteric studies and adult women’s health and medicine, including underlying endocrinological changes, treatment of the symptoms of the menopause and other age-related changes, hormone replacement therapies, alternative therapies, effective life-style modifications, non-hormonal midlife changes, and the counselling and education of perimenopausal and postmenopausal patients. In addition, the journal features regular invited expert editorials and reviews, comments on recently published papers and a correspondence section.
Key sales features
Authoritative – has the backing of the IMS
Wide-ranging academic content – appeals to broad range of subscribers
Offers rapid peer-review and rapid publication of key research findings
Outstanding Editorial Board of international opinion leaders
Wide circulation (including all members of the IMS)
All published research articles in this journal have undergone rigorous peer review, based on initial editor screening and anonymous reviewing by independent reviewers.
ABSTRACTING AND INDEXING
Climacteric is covered by: Science Citation Index, SciSearch, EMBASE/Excerpta Medica, Index Medicus/MEDLINE, and SIIC (Sociedad Iberoamericana de Información Científica).
Instructions for Authors
Submitted manuscripts will be processed by the Editors-in-Chief, with the following split in geographical areas: Europe, Turkey and Middle East: Mr Nick Panay, Queen Charlotte’s & Chelsea Hospital, London, UK. Email: firstname.lastname@example.org Rest of the World: Dr Anna Fenton, Endocrinologist, Christchurch Women's Hospital, University of Otago School of Medicine, Christchurch, New Zealand. E-mail: email@example.com
Managing Editor: Mrs Jean Wright, firstname.lastname@example.org
Editorial Assistant: Mrs Susan Brown, email@example.com
The following link gives access to our Writer´s Guide. This contains information to support your submission to Climacteric. It should be read in addition to the Instructions for Authors.
It is a condition of publication that the authors transfer the world copyright of their manuscripts to the International Menopause Society. This ensures full copyright protection and allows dissemination of the article, and the Journal, to the widest possible readership in print and electronic formats. All material should conform to the uniform requirements for manuscripts submitted to biomedical journals (Uniform requirements for manuscripts submitted to biomedical journals. International Committee of Medical Journal Editors. Ann Intern Med 1997;126:36–47). Authors submitting reports of randomized clinical trials should ensure that their report conforms to the CONSORT Statement (http://www.consort-statement.org; CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010;152:726–32. See also Moher D, et al. for the CONSORT Group. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomized trials. J Clin Epidemiol 2010;63:e1-37). This journal adheres strictly to the Committee of Publication Ethics (COPE) guidelines
(http://publicationethics.org/resources/code-conduct) on good publication practice (see Hum Reprod 2001;16:1783–8). Submission of a paper implies that it reports unpublished work and that it is not under consideration for publication elsewhere.
Authors will normally be entitled to publish any part of their paper elsewhere provided permission is requested and the usual acknowledgements are given. The assignment of the copyright will not affect subsisting patent rights or arrangements relating to them. Illustrations, tables or quotations from other publications are already copyrighted and can be reproduced only with written permission from the copyright owner. Written permission to use these should accompany the manuscript.
For further details and frequently asked questions on Informa UK Ltd’s policy on copyright and authors’ rights, refer to: http://authorservices.taylorandfrancis.com/?s=copyright
The Editors and Publisher support the principles of the Declaration of Helsinki and expect that the authors of papers submitted to the Journal will have obtained ethical consent and followed those legal and regulatory requirements for human experimentation with drugs, including informed consent, according to procedures which apply in their institution and country.
AUTHORITY AND RESPONSIBILITY
The intellectual content of the paper is the responsibility of the authors. The Editors and the Publisher accept no responsibility for opinions and statements of authors. While every effort will be made by the Editors and Publisher to avoid inaccurate and misleading data, they accept no liability whatsoever for the consequences of wrong information.
The authors agree to keep the Editors and Publisher fully and effectually indemnified against any liability or claims that may arise out of the publication of inaccurate and/or misleading data.
Acknowledgements: The scientific and material contributions of others to the work should be acknowledged, with their written permission. Any grant supports should be listed and permission for reproduction of published material acknowledged.
Declaration of interest: It is the policy of all Informa Healthcare to adhere in principle to the Conflict of Interest policy recommended by the International Committee of Medical Journal Editors (ICMJE, http://www.icmje.org/about-icmje/faqs/conflict-of-interest-disclosure-forms/).
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. It is the sole responsibility of authors to disclose any affiliation with any organization with a financial interest, direct or indirect, in the subject matter or materials discussed in the manuscript (such as consultancies, employment, paid expert testimony, honoraria, speakers’ bureaus, retainers, stock options or ownership, patents or patent applications or travel grants) that may affect the conduct or reporting of the work submitted. All sources of funding for research are to be explicitly stated. If uncertain as to what might be considered a potential conflict of interest, authors should err on the side of full disclosure.
All submissions to the journal must include full disclosure of all relationships that could be viewed as presenting a potential conflict of interest. If there are no conflicts of interest, authors should state that there are none. This must be stated at the point of submission (within the manuscript after the main text under a subheading ‘Conflict of interest’ and, where available, within the appropriate field on Climacteric’s ScholarOne Manuscripts site). This may be made available to reviewers and will appear in the published article at the discretion of the Editors or Publisher.
If no conflict is declared, the statement below will be attached to all articles. The intent of this policy is not to prevent authors with these relationships from publishing work, but rather to adopt transparency such that readers can make objective judgments on conclusions drawn.
Conflict of interest The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.
Source of funding All sources of funding for research must be explicitly stated at the end of the manuscript. This information will also be published at the end of each paper.
All manuscripts submitted to the journal will undergo rigorous peer review, based on initial editor screening and anonymous reviewing by independent reviewers. Further details can be found under the section Submission of manuscripts, Step 4.
PREPARATION OF MANUSCRIPTS
Presentation: Most standard PC or Mac word-processing software packages are acceptable, although we prefer Microsoft Word in a PC format. A manuscript should not be submitted in a PDF file because it is then impossible to prepare for typesetting. Papers should be structured into headed sections as follows: Title page, Abstract, Introduction, Methods, Results, Discussion, Acknowledgements and References. Each section should begin on a new page. Other subsection headings within the main headings may be used but should be limited. Section headings should be no longer than 55 characters, including spaces.
The Title page: (included in the complete manuscript and uploaded as ‘File not for review’) should include: title, first and last name of the authors and their affiliations, short title (no more than 20 letters), key words (3–8), and the address for correspondence, including telephone, facsimile numbers and e-mail address. The Abstract of an Original research article should clearly set out the objectives, methods, results, and conclusions, making the information instantly available to readers. The Introduction should be limited to the specific background necessary to show the importance and context of the current study. The objective of the study should be clearly stated in the final paragraph of the Introduction. The Results section should avoid overlap between tables, figures and text. The Discussion section should begin with a succinct statement of the principal findings, outline the strengths and weaknesses of the study, discuss the findings in relation to other studies, provide possible explanations, and indicate questions which remain to be answered in future research.
Papers should be of a length appropriate for the amount of information they contain. Failure to restrict the length, especially of the Introduction and Discussion sections, can negatively influence the reviewers’ and the Editors’ decisions. As a general guide, the following restrictions are suggested:
Reviews: The length should be no more than 3500 words, with ≤ 100 references. An abstract with ≤ 200 words must be provided; this does not need to be structured. Tables and/or figures should be restricted to two or three and should not occupy more than two journal pages. Additional tables and figures can be submitted as Supplementary data to be published online only (see section on Supplementary material).
Short reviews: These should be no more than 1000 words, with ≤ 10 references and an unstructured abstract of ≤ 200 words.
Original research articles: An original research article should be no more than 3000 words in length, with
≤ 50 references. A structured abstract must be provided, with ≤ 200 words and with headings such as Objectives, Method, Results, Conclusion. Tables and/or figures should be restricted to two or three and should not duplicate information in the text of the paper. They should not occupy more than two journal pages. Additional tables and figures can be submitted as Supplementary data to be published online only (see section on Supplementary material).
Short reports: A Short report should be ≤ 2000 words in length, with ≤ 30 references and one or two figures or tables. An abstract of no more than 200 words must be provided; this does need to be structured.
Invited Editorial/Commentary/Opinion: These should be no more than 1500 words in length, with ≤ 20 references and un unstructured abstract of ≤ 200 words .
Authors of submitted manuscripts that exceed the journal limits on words, tables, figures and references should be aware that they may be asked to reduce the text and re-submit their manuscript before it can be peer reviewed. The word count covers the text from the Introduction to the Conclusion and does not include the abstract, references, tables and figures, for which there are separate restrictions.
Style: Authors whose native language is not English are requested to have their manuscript checked for linguistic correctness before submission. However, the Journal has a policy of encouraging the submission of good papers from authors whose first language is not English. Although articles must be written in English, authors will not be penalized on linguistic grounds by referees. In appropriate circumstances, the Editors will contribute to an improvement of the language used.
Abbreviations and symbols must be standard and SI units must be used throughout. Statistical analyses must explain the methods used. The use of footnotes is not permitted. References to drugs should be by their approved, not proprietary names, and the source of any new or experimental preparations should be given.
The Editors reserve the right to alter the manuscripts whenever necessary to make them conform to the stylistic and bibliographic conventions of the Journal.
Literature cited: Authors are responsible for the accuracy of the references. References should be numbered consecutively throughout the text and cited as superscript numerals before any punctuation, e.g. 'Jones and colleagues have reported on recent work on noise-induced deafness21.' The references should be listed in full at the end of the article in Vancouver style, paying particular attention to the following:
• Journal and book titles should be in italic.
• The names and initials of all authors should be given (unless there are more than six, when only the first three should be given, followed by et al.).
• Medical journal abbreviations follow Index Medicus usage.
• The journal volume number should be given but not the month of publication or issue number.
• Unpublished work, work in preparation or personal communications should not be used as references but merely mentioned in the text.
• Authors must verify references against the original documents before submitting the manuscript. References should be set out in the style of the following examples:
JOURNAL ARTICLE: Pike MC, Peters RK, Cozen W, et al. Estrogen–progestin replacement therapy and endometrial cancer. J Natl Cancer Inst 1997;89:1110–16
IN PRESS: (fill in current year): Evans GL, Turner RT. Tissue-selective actions of estrogen analogs. Bone 20–; in press
BOOK: Guyton AC. Circulatory Physiology: Cardiac Output and its Regulation. Philadelphia: Saunders, 1963:127–30
ARTICLE IN AN EDITED BOOK: Meade TW. Epidemiology of thrombosis. In Loscalzo J, Schafer AI, eds.
Thrombosis and Hemorrhage, Vol 2. Oxford: Blackwell Scientific, 1994:791–808
PUBLISHED ABSTRACTS: Christiansen JS. Growth hormone, growth hormone secretagogues and aging. Presented at The First World Congress on the Aging Male, Geneva, February 1998. Aging Male 1998;1:6, Abstr 11
Illustrations: Digital images are necessary and should be of high resolution. Any lettering must be large enough to permit a reduction in size. Illustrations must be saved individually and separately to the text. Please do not embed illustrations in the manuscript file.
Avoid the use of color and tints for purely esthetic reasons. Any figure submitted as a color original will appear in color in the journal’s online edition free of charge and can be downloaded. Color reproduction in the printed version of the journal may be considered at the Editors’ discretion but authors may be asked to contribute to the associated costs. Color costs will be waived for invited Review Articles.
Reference should be made specifically in the text to all figures. They should be numbered Figure 1, Figure 2, etc. Do not include more figures than are absolutely necessary – non-essential figures may be judged as being suitable for online-only publication (see section on Supplementary material).
The use of symbols in illustrations should be consistent with usage within the paper. Legends for illustrations should be collected together and presented on a separate manuscript page. Each legend must be self-contained, with all symbols and abbreviations used in the figure defined. Figure and axes titles should be clear and NOT in bold text. All photographs should be of the highest quality possible, as reproduction reduces the quality. When photomicrographs are submitted, staining techniques should be stated and an internal scale marker included.
Files containing illustrations should be saved as one of the following formats: TIFF (tagged image file format), JPG, PostScript or EPS (encapsulated PostScript) and should contain all the necessary font information and the source file of the application (e.g. CorelDraw/Mac, CorelDraw/PC). If any of the illustrations submitted have been published elsewhere, written consent should be obtained from the copyright holder (usually the publisher) and the authors.
Tables: Do not include more tables than are absolutely necessary. Non-essential tables may be judged as being suitable for online publication only (see section on Supplementary material). Each table should be submitted in the manuscript on a separate page, together with its caption. The following symbols should be used for foot notes: *, †, ‡, **. References should be made specifically in the text to all tables. They should be numbered Table 1, Table 2, etc. Please avoid complex constructions. Each table should be constructed in Word format and each item of data should be in a separate cell. Tables should not duplicate information in the text of the paper. If any of the tables submitted have been published elsewhere, written consent should be obtained from the copyright holder (usually the publisher) and the authors.
The space available in the printed journal is restricted and authors are therefore encouraged to be as concise as possible in their writing and to consider having supplementary material for publication only in the online version of the journal. Supplementary material consists of additional documents or data that add background detail to the article but are not core to its discussion or conclusions. The online manuscript submission process allows authors to upload the supplementary material at the same time as the main text submission. It is very important that the authors indicate adequately what documents (including captions and legends of tables and figures) are not to be printed, both when referring to the material in the main text as well as in the file designation when uploading the files (select from the dropdown menu the tab marked ‘Supplemental File’).
Supplemental digital content may enhance an article’s text and may include text documents, questionnaires, tables, and figures. Authors reporting results from a questionnaire survey should include a copy of the questionnaire used together with the manuscript, unless the questionnaire is in common use and published before, when a reference will suffice. Do not include supplementary material within the main manuscript file, but upload as separate file(s).
Cite all supplemental digital content consecutively in the text. Include a sequential number (S1, S2, S3, etc.) and provide a brief description of the supplemental content. Provide legends for the supplemental content at the end of the text. List the legends in the order in which the material is cited in the text. The legends must be numbered to match the citations from the text.
Documents, graphs, and tables may be presented in any format. Figures should be submitted with the following file extensions: .tif, .eps, .ppt, .jpg, .pdf.
SUBMISSION OF MANUSCRIPTS
Articles will be published in the following classifications: Original research articles, Reviews, Short reviews, Invited Editorials, Short reports, Case reports, Book reviews, Commentaries, Opinions, and Letters to the Editors.
All submissions should be made online at Climacteric’s ScholarOne Manuscripts site: http://mc.manuscriptcentral.com/dcli. New users should first create an account. Your User name will be your e-mail address; please remember which e-mail address you have used and use the same one at all times to access the site. Please make a note of your password. If you do forget it, contact Susan Brown (firstname.lastname@example.org). Once a user is logged onto the site, submissions should be made via the Author Center.
There are six steps in the submission process:
1. Type, title and abstract You are requested first to select the type of article from a dropdown menu (original article, review, short report, etc. – see information in the section on Preparation of manuscripts); next, you are asked to give the title of the paper which should be no longer than 100 characters including spaces. You must also provide at this stage the Abstract of the paper (this allows the Editors to review the Abstract quickly so that they can request relevant referees to review the paper); the Abstract should not exceed 200 words. If you need to insert a special character, click the ‘Special characters’ button.
2. Key words You are requested to list at least three and no more than eight key words for the manuscript. The key words, together with the title and abstract, are used for online searches. They should therefore be specific and relevant to the paper.
3. Authors and institutions The names, affiliations and e-mail addresses of the corresponding author and co-authors must be provided. So that there is no confusion, please provide the family name in full but only the initials for the given names of each author. The name of the corresponding author must be clearly designated and the full postal address, telephone number and e-mail address of this individual must be given. The proofs of the paper will be sent to this author. Please check with your co-authors that their e- mail addresses are accurate. Incorrect data can lead to delay in acceptance of your submission and co- authors will not be informed of the submission..
4. Details and comments In this section, you should provide your covering letter to the Editors, explaining your submission. The covering letter can be typed in the space provided or uploaded as a file attachment by selecting the Choose File Button, followed by selecting the Attach File icon. The cover letter should not be uploaded as a supplemental file. You are also asked to answer a list of questions, the most important of which concern any previous submission of the manuscript to the journal, conflicts of interest, sources of funding for the study, where your submission is from (Europe, Turkey, Middle East or Rest of the world), understanding of copyright and author rights, and manuscript information. You must state any conflicts of interest and sources of funding.
5. File upload
• In this very important step, you are asked to upload the files for your manuscript. You should prepare and upload two versions of the manuscript. Both should be Word files, not PDF files.
• The first version, entitled ‘File not for review’, should contain the complete text, including title, authors,
affiliations, abstract, correspondence address, key words and tables.
• The second version, entitled ‘Main Document’, should be the same as the first document but all information identifying the authors (names, e-mail addresses, addresses and affiliations) should be removed, to allow this document to be sent anonymously to referees. In this second file, if any reference is to your own previous work, you should state at the side of this reference that the details have been blinded for peer review and omit the details of the reference.
• Please ensure that both documents have the same number of pages by providing only the title on the first page in the Main Document for peer review, to avoid possible confusion at the review stage.
• It is preferable for the tables to be included in these two versions of the manuscript. If, however, the size of any table makes this inclusion difficult, it may be uploaded as a separate file, selecting from the dropdown menu the tab marked ‘Tables’.
• Figures should be uploaded as separate files, selecting from the dropdown menu the tab marked ‘Figures’.
• Remember that Supplemental data, for online publication only, should be uploaded using the tab marked ‘Supplemental File’.
6. Review and submit In the last step, you are requested to check all the submitted data for correctness before finally submitting the manuscript. Any areas that have not been completed will appear marked with a cross; submission will not be possible until these areas are completed.
There are seven steps in the submission process:
If you experience any difficulty in following the submission process, you are invited to contact Susan Brown, Editorial Assistant (email@example.com) for assistance.
You can monitor the progress of your manuscript by checking your submission in your Author Center. However, if you have any queries regarding the status of your manuscript at any stage from submission to acceptance/rejection, please contact Susan Brown at (firstname.lastname@example.org).
You will receive an e-mail from the Editor-in-Chief after peer review to advise whether your manuscript has been accepted or rejected or whether any major or minor revision is required.
REVISION OF MANUSCRIPTS AFTER PEER REVIEW
The e-mail from the Editors requesting major or minor revisions will list the comments from the peer reviewers. You will be able to find the original manuscript files at http://mc.manuscriptcentral.com/dcli – Author Center, under: My Manuscripts, Manuscripts with decisions. The manuscript number will have been appended to denote a revision, using the appendix R1 or R2.
When you revise your manuscript, please highlight the changes you make in the manuscript by using the track changes mode in MS Word or by using bold or colored text.
To submit the revised manuscript, do so via http://mc.manuscriptcentral.com/dcli – Author Center; under ‘Actions’, click on ‘Create a Revision’. As with the original submission, two documents of identical page length must be uploaded, but one must be anonymous for peer review (see full details under Step 6 of original submission). Make sure that you delete any original redundant files before completing the submission.
Enter your responses to comments made by the reviewer(s) in the space provided. You can use this space to document any changes you have made to the original manuscript. Please be as specific as possible in your response to the reviewer(s).
Climacteric normally allows a month for the submission of revisions. In some circumstances it may be possible to extend this period by contacting Susan Brown (email@example.com).
ACCEPTANCE OF MANUSCRIPTS
The Editor-in-Chief will advise authors when their manuscript has been accepted by e-mail; accepted manuscripts will be transferred from the online submission site to the online production site (Central Article Tracking System, CATS). You will receive an e-mail from the Production Editor informing you of your sixdigit tracking number, user name and password to access CATS and to track the progress of the manuscript through the typesetting and publishing process. Corresponding authors will also receive a copyright transfer form, which must be signed immediately and uploaded into CATS or e-mailed/faxed to the Production Editor. Manuscripts cannot be published in any form if the publisher does not receive the copyright transfer.
To facilitate the quickest possible time from submission of your paper to publication of a citable article, there are three stages: Just Accepted, publication online as Early Online, and, finally, publication in an issue of the journal. Providing your copyright form has been received, your paper will be published online on Just Accepted within a few days of formal acceptance. Unless you inform the Production Editor immediately that you do not wish your paper to be published in this provisional format, your paper will be automatically published on Just Accepted. Just Accepted articles will appear as submitted by the authors and will not have undergone any copyediting, typesetting, or proofreading. A citation record will be sent to PubMed, which will be updated at the time as your article is published online after copy-editing and typesetting.
After copy-editing, each manuscript is typeset and the designated author will receive via e-mail a notification from the Production Editor to check the proofs; the PDF file of the article can be downloaded from CATS and should be read carefully for errors. There may be some queries from the Production Editor about the text. The corresponding author must send their approval, with any corrections and answers to queries to the Production Editor within 1 week, either via CATS or by e-mail. It is the authors’ responsibility to check that all the text and data as contained in the page proofs are correct and suitable for publication. We request that authors pay particular attention to author names and affiliations as it is essential that these details are accurate when the article is published. Authors may be asked to defray the expense of any major alterations to the proofs which are departures from the original manuscript.
The proofs are then corrected and checked; after final approval they are published online and indexed in PubMed. Publication in print takes place when scheduled by the Editors-in-Chief. Authors are offered a PDF of the final paper, discounted prices for reprints, and iOpen Access.
All authors will be given the option of publishing their accepted articles on an Open Access basis, at an additional charge. Paying for open access allows their article to be made freely available online immediately after publication. Authors will be advised about the iOpen Access option when they are notified that their proofs are available in CATS for checking. The option will be mediated via a simple, user-friendly e-commerce system which will facilitate online credit card payment.
OFFPRINTS AND REPRINTS
When the article is published online, an automated e-mail is sent to the corresponding author with a link to where he/she can download the PDF file of the article. Offprints and reprints of articles published in this journal can be purchased once the article has been published online. Reprints of articles published in this journal can be purchased when proofs are received. Copies of the Journal can be purchased at the authors’ preferential rate of £15.00/$25.00 per copy, and must also be ordered at proofing stage to enjoy this rate.
NIH PUBLIC ACCESS POLICY
In consideration of the National Institutes of Health (NIH) Public Access Policy, Informa Healthcare acknowledges that the broad and open dissemination of NIH-funded research results may benefit future scientific and medical research. Because we value the current and future contributions that our journals make to the scientific body of knowledge, we have made certain that our policies accommodate those authors who wish to submit to PubMed Central.
Informa Healthcare’s position with respect to public access to NIH-funded work published in Informa Healthcare journals is as follows:
• Informa Healthcare authors may voluntarily submit their funded work to PubMed Central after a 12-month embargo period;
• ‘Funded work’ shall be defined as the final, peer-reviewed manuscript that is accepted by the Editors-in-Chief of the journal. This manuscript must not be altered by Publisher’s copyediting and typesetting services; and
• This embargo period begins the day the work is published online on this website